Cardinal Health, a healthcare supply chain company, has been approved to close a proposed acquisition of Kinray, a pharmaceutical distributor serving in the New York metropolitan area, according to a news release.
Under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, both parties in a merger or acquisition transaction must file a proposal of the transaction to the government before the sale is closed. After filing the proposal, there is a 30-day waiting period, during which time regulatory agencies assess whether the proposed transaction does or does not violate U.S. antitrust laws.
The Federal Trade Commission has granted early termination of the waiting period.
Read the news release about Cardinal Health's acquisition of Kinray.
Read other coverage about supply chain:
- 5 Ways to Control OR Supply Costs
- 6 Recent Articles on Ambulatory Surgery Center Reprocessing
- Amerinet Names New Executive Vice President of Sales
Under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, both parties in a merger or acquisition transaction must file a proposal of the transaction to the government before the sale is closed. After filing the proposal, there is a 30-day waiting period, during which time regulatory agencies assess whether the proposed transaction does or does not violate U.S. antitrust laws.
The Federal Trade Commission has granted early termination of the waiting period.
Read the news release about Cardinal Health's acquisition of Kinray.
Read other coverage about supply chain:
- 5 Ways to Control OR Supply Costs
- 6 Recent Articles on Ambulatory Surgery Center Reprocessing
- Amerinet Names New Executive Vice President of Sales